The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Pliant Therapeutics, Inc(NASDAQ:PLRX) 
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of av6 and ...
Website: http://www.pliantrx.com
Founded: 2015
Full Time Employees: 70
CEO: Bernard Coulie
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Pliant Therapeutics Days Payable Outstanding ttm (DPO)
Pliant Therapeutics Days Receivable Outstanding ttm (DSO)
Pliant Therapeutics Op Cashflow Per Share ttm
Pliant Therapeutics Free Cashflow Per Share ttm
Pliant Therapeutics Cash Per Share ttm
Pliant Therapeutics P/S ratio ttm
Pliant Therapeutics (GAAP) P/E ratio ttm
Pliant Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.